Elsbernd Brian's Form 4 filing
Catalyst Pharmaceuticals, Inc. (CPRX) · filed Jul 17, 2026
- Accession no.
- 0001161697-26-000176
- Filed
- Jul 17, 2026, 4:15 PM ET
- Trade date
- Jul 15, 2026
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 10 derivative transactions. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Elsbernd BrianCIK 0001763511 | Officer (Chief Legal Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Common Stock, par value $0.001 per share | DReturned to the companyDisposed | −242,501 | $31.50 | −$7,638,781.5 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −132,000 | $0.00 | $0 | 0 | Direct | |
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −200,000 | $0.00 | $0 | 0 | Direct | |
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −135,000 | $0.00 | $0 | 0 | Direct | |
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −69,000 | $0.00 | $0 | 0 | Direct | |
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −147,621 | $0.00 | $0 | 0 | Direct | |
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −126,704 | $0.00 | $0 | 0 | Direct | |
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −98,652 | $0.00 | $0 | 0 | Direct | |
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −7,067 | $0.00 | $0 | 0 | Direct | |
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −10,322 | $0.00 | $0 | 0 | Direct | |
| Jul 15, 2026 | Common Stock | DReturned to the companyDisposed | −29,776 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.